vs
Side-by-side financial comparison of Beta Bionics, Inc. (BBNX) and Rumble Inc. (RUM). Click either name above to swap in a different company.
Beta Bionics, Inc. is the larger business by last-quarter revenue ($27.6M vs $27.1M, roughly 1.0× Rumble Inc.). Beta Bionics, Inc. runs the higher net margin — -79.3% vs -120.8%, a 41.5% gap on every dollar of revenue. On growth, Beta Bionics, Inc. posted the faster year-over-year revenue change (56.6% vs -10.5%).
Beta Bionics, Inc. is a medical technology company focused on developing and commercializing advanced automated diabetes management solutions. Its core product is the iLet Bionic Pancreas, a wearable device that automatically adjusts insulin and glucagon delivery for people with Type 1 and Type 2 diabetes, serving primarily the U.S. healthcare market with plans for global expansion.
Rumble is a Canadian-American online video platform, web hosting, and cloud services business headquartered in Toronto, Canada, with its U.S. headquarters in Longboat Key, Florida. It was founded in 2013 by Chris Pavlovski, a Canadian technology entrepreneur. Rumble's cloud services business hosts Truth Social, and the video platform is popular among American conservative and far-right users. Rumble has been described as "alt-tech".
BBNX vs RUM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $27.6M | $27.1M |
| Net Profit | $-21.9M | $-32.7M |
| Gross Margin | 59.5% | 5.5% |
| Operating Margin | -47.4% | -131.1% |
| Net Margin | -79.3% | -120.8% |
| Revenue YoY | 56.6% | -10.5% |
| Net Profit YoY | 23.6% | 86.2% |
| EPS (diluted) | $-0.49 | $-0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $27.6M | — | ||
| Q4 25 | $32.1M | $27.1M | ||
| Q3 25 | $27.3M | $24.8M | ||
| Q2 25 | $23.2M | — | ||
| Q1 25 | $17.6M | $23.7M | ||
| Q4 24 | — | $30.2M | ||
| Q3 24 | — | $25.1M | ||
| Q2 24 | — | $22.5M |
| Q1 26 | $-21.9M | — | ||
| Q4 25 | $-13.5M | $-32.7M | ||
| Q3 25 | $-14.2M | $-16.3M | ||
| Q2 25 | $-16.9M | — | ||
| Q1 25 | $-28.7M | $-2.7M | ||
| Q4 24 | — | $-236.8M | ||
| Q3 24 | — | $-31.5M | ||
| Q2 24 | — | $-26.8M |
| Q1 26 | 59.5% | — | ||
| Q4 25 | 59.0% | 5.5% | ||
| Q3 25 | 55.5% | -1.8% | ||
| Q2 25 | 53.8% | — | ||
| Q1 25 | 50.9% | -26.7% | ||
| Q4 24 | — | -14.2% | ||
| Q3 24 | — | -45.4% | ||
| Q2 24 | — | -58.8% |
| Q1 26 | -47.4% | — | ||
| Q4 25 | -50.2% | -131.1% | ||
| Q3 25 | -62.5% | -113.6% | ||
| Q2 25 | -85.5% | — | ||
| Q1 25 | -105.7% | -153.5% | ||
| Q4 24 | — | -80.1% | ||
| Q3 24 | — | -131.0% | ||
| Q2 24 | — | -172.7% |
| Q1 26 | -79.3% | — | ||
| Q4 25 | -41.9% | -120.8% | ||
| Q3 25 | -52.1% | -65.7% | ||
| Q2 25 | -72.6% | — | ||
| Q1 25 | -162.5% | -11.2% | ||
| Q4 24 | — | -783.2% | ||
| Q3 24 | — | -125.9% | ||
| Q2 24 | — | -119.2% |
| Q1 26 | $-0.49 | — | ||
| Q4 25 | $-0.16 | $-0.13 | ||
| Q3 25 | $-0.33 | $-0.06 | ||
| Q2 25 | $-0.39 | — | ||
| Q1 25 | $-0.93 | $-0.01 | ||
| Q4 24 | — | $-1.17 | ||
| Q3 24 | — | $-0.15 | ||
| Q2 24 | — | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $199.5M | $237.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $271.2M | $274.8M |
| Total Assets | $304.4M | $336.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $199.5M | — | ||
| Q4 25 | $219.1M | $237.9M | ||
| Q3 25 | $228.7M | $269.8M | ||
| Q2 25 | $249.7M | — | ||
| Q1 25 | $231.5M | $301.3M | ||
| Q4 24 | — | $114.0M | ||
| Q3 24 | — | $132.0M | ||
| Q2 24 | — | $154.2M |
| Q1 26 | $271.2M | — | ||
| Q4 25 | $287.6M | $274.8M | ||
| Q3 25 | $294.8M | $302.2M | ||
| Q2 25 | $301.6M | — | ||
| Q1 25 | $313.8M | $339.6M | ||
| Q4 24 | — | $-63.1M | ||
| Q3 24 | — | $166.1M | ||
| Q2 24 | — | $192.7M |
| Q1 26 | $304.4M | — | ||
| Q4 25 | $328.7M | $336.8M | ||
| Q3 25 | $330.0M | $367.2M | ||
| Q2 25 | $330.0M | — | ||
| Q1 25 | $338.0M | $391.1M | ||
| Q4 24 | — | $195.3M | ||
| Q3 24 | — | $217.2M | ||
| Q2 24 | — | $243.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-29.4M |
| Free Cash FlowOCF − Capex | — | $-31.7M |
| FCF MarginFCF / Revenue | — | -117.2% |
| Capex IntensityCapex / Revenue | — | 8.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-70.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-8.6M | $-29.4M | ||
| Q3 25 | $-8.7M | $-10.6M | ||
| Q2 25 | $-13.6M | — | ||
| Q1 25 | $-20.0M | $-14.5M | ||
| Q4 24 | — | $-12.4M | ||
| Q3 24 | — | $-19.1M | ||
| Q2 24 | — | $-21.7M |
| Q1 26 | — | — | ||
| Q4 25 | $-10.5M | $-31.7M | ||
| Q3 25 | $-10.0M | $-12.0M | ||
| Q2 25 | $-15.4M | — | ||
| Q1 25 | $-20.3M | $-14.6M | ||
| Q4 24 | — | $-12.4M | ||
| Q3 24 | — | $-19.9M | ||
| Q2 24 | — | $-23.1M |
| Q1 26 | — | — | ||
| Q4 25 | -32.8% | -117.2% | ||
| Q3 25 | -36.7% | -48.6% | ||
| Q2 25 | -66.2% | — | ||
| Q1 25 | -115.1% | -61.7% | ||
| Q4 24 | — | -40.9% | ||
| Q3 24 | — | -79.5% | ||
| Q2 24 | — | -102.8% |
| Q1 26 | — | — | ||
| Q4 25 | 5.9% | 8.5% | ||
| Q3 25 | 4.7% | 5.7% | ||
| Q2 25 | 7.7% | — | ||
| Q1 25 | 1.9% | 0.6% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 3.4% | ||
| Q2 24 | — | 6.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BBNX
Segment breakdown not available.
RUM
| Audience Monetization | $23.8M | 88% |
| Other Initiatives | $3.3M | 12% |
